150 related articles for article (PubMed ID: 38622523)
1. Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
You X; Qiu J; Li Q; Zhang Q; Sheng W; Cao Y; Fu W
BMC Cancer; 2024 Apr; 24(1):472. PubMed ID: 38622523
[TBL] [Abstract][Full Text] [Related]
2. [Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].
You XJ; Wen Z; Zheng QX; Li QX; Fu W; Li HS; Wang B
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):963-972. PubMed ID: 38639947
[TBL] [Abstract][Full Text] [Related]
3. Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.
You X; Wu Y; Li Q; Sheng W; Zhou Q; Fu W
Front Pharmacol; 2022; 13():895696. PubMed ID: 35847007
[No Abstract] [Full Text] [Related]
4. Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice
Du XQ; Shi LP; Chen ZW; Hu JY; Zuo B; Xiong Y; Cao WF
Front Cell Infect Microbiol; 2022; 12():836150. PubMed ID: 35656031
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Prevents Memory Impairment in D-galactose-induced Aging Rats Via the AGEs/RAGE/ NF-κB Axis.
Li W; Wang S; Wang H; Wang J; Jin F; Fang F; Fang C
Arch Med Res; 2022 Jan; 53(1):20-28. PubMed ID: 34217517
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation.
He Q; Han C; Huang L; Yang H; Hu J; Chen H; Dou R; Ren D; Lin H
J Cell Mol Med; 2020 Aug; 24(16):9349-9361. PubMed ID: 32628809
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV ameliorate acute alcohol-induced liver injury in mice
Wu S; Wen F; Zhong X; Du W; Chen M; Wang J
Ann Med; 2023 Dec; 55(1):2216942. PubMed ID: 37243569
[TBL] [Abstract][Full Text] [Related]
8. ASTRAGALOSIDE Ⅳ MODULATES GUT MACROPHAGES M1/M2 POLARIZATION BY RESHAPING GUT MICROBIOTA AND SHORT CHAIN FATTY ACIDS IN SEPSIS.
Yang T; Xie S; Cao L; Li M; Ding L; Wang L; Pang S; Wang Z; Geng L
Shock; 2024 Jan; 61(1):120-131. PubMed ID: 37962207
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV Mitigated Diabetic Nephropathy by Restructuring Intestinal Microflora and Ferroptosis.
Lyu X; Zhang TT; Ye Z; Chen C
Mol Nutr Food Res; 2024 Mar; 68(6):e2300734. PubMed ID: 38389170
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT/NF-κB signaling pathway.
He Y; Zhang Q; Chen H; Guo Q; Zhang L; Zhang Z; Li Y
Biochem Cell Biol; 2021 Apr; 99(2):214-222. PubMed ID: 32813978
[TBL] [Abstract][Full Text] [Related]
11. The effects of astragaloside IV on gut microbiota and serum metabolism in a mice model of intracerebral hemorrhage.
Li Z; Hu E; Zheng F; Wang S; Zhang W; Luo J; Tang T; Huang Q; Wang Y
Phytomedicine; 2023 Dec; 121():155086. PubMed ID: 37783132
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of astragaloside Ⅳ on Toll-like receptor pathway in fibrotic mice after renal ischemia-reperfusion].
Yang RQ; Xu Q; Huangfu ZM; Zhang CL; Yin YF; Zhang J; Zhao CL
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3729-3739. PubMed ID: 30384540
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice.
Xu N; Kan P; Yao X; Yang P; Wang J; Xiang L; Zhu Y
J Microbiol; 2018 Nov; 56(11):838-846. PubMed ID: 30353470
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids.
Lachance G; Robitaille K; Laaraj J; Gevariya N; Varin TV; Feldiorean A; Gaignier F; Julien IB; Xu HW; Hallal T; Pelletier JF; Bouslama S; Boufaied N; Derome N; Bergeron A; Ellis L; Piccirillo CA; Raymond F; Fradet Y; Labbé DP; Marette A; Fradet V
Nat Commun; 2024 Apr; 15(1):3431. PubMed ID: 38654015
[TBL] [Abstract][Full Text] [Related]
16. Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model.
Chen Z; He S; Wei Y; Liu Y; Xu Q; Lin X; Chen C; Lin W; Wang Y; Li L; Xu Y
Front Cell Infect Microbiol; 2023; 13():1150043. PubMed ID: 37180443
[TBL] [Abstract][Full Text] [Related]
17. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
[TBL] [Abstract][Full Text] [Related]
18. Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer.
Konopka CJ; Woźniak M; Hedhli J; Siekierzycka A; Skokowski J; Pęksa R; Matuszewski M; Munirathinam G; Kajdacsy-Balla A; Dobrucki IT; Kalinowski L; Dobrucki LW
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2562-2576. PubMed ID: 32166512
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization.
Liu Y; Zhou Q; Ye F; Yang C; Jiang H
Neoplasia; 2023 Sep; 43():100928. PubMed ID: 37579688
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
